ACAntoine Chrabie

Antoine Chrabie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Antoine Chrabie has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Abdo Jurjus

    Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut 1107-2020, Lebanon

    1 shared publication
  • Alice Gerges Geagea

    Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Riad El-Solh/Beirut 1107 2020, Lebanon

    1 shared publication
  • Angelo Leone

    Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy

    1 shared publication
  • Celine Al Kazzi

    Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Riad El-Solh/Beirut 1107 2020, Lebanon

    1 shared publication
  • Dalia Berjass

    Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Riad El-Solh/Beirut 1107 2020, Lebanon

    1 shared publication
  • Francesco Cappello

    Department of Biomedicine, Neurosciences and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy

    1 shared publication

Latest Publications

  • Open Access

    Salivary biomarkers in inflammatory bowel disease

    by Antoine Chrabie, Celine Al Kazzi, Dalia Berjass, Alice Gerges Geagea, Laura Dosh, Lavinia Giovanna Leone, Sahar Al Kattar, Naim Ouaini, Francesco Cappello, Angelo Leone, et al.

    Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic immune-mediated condition typically requiring invasive endoscopy for monitoring. The bidirectional oral-gut axis suggests that saliva may serve as a non-invasive diagnostic fluid for studying gut inflammations. Studies of salivary biomarkers have shown varying results. Inflammatory biomarkers such as IL-6 are the most robust salivary biomarker, consistently correlating with endoscopic activity. In contrast, salivary calprotectin lacks the reliability of its fecal counterpart, showing diagnostic value primarily in pediatric cases with oral manifestations. Microbial analysis indicates reduced salivary diversity, specifically an enrichment of Prevotella and Veillonella alongside a depletion of core commensals like Streptococcus. While oxidative stress markers such as advanced oxidation protein products (AOPPs) can distinguish disease severity, they lack long-term prognostic utility. Conversely, recent shifts toward exosome-based transcriptomic analysis have improved the stability of salivary microRNAs, offering high precision in differentiating IBD phenotypes. Despite these advancements, clinical integration is currently hindered by small cohort sizes, the confounding effects of local oral health, and a lack of standardized collection protocols. To establish saliva as a reliable tool in the IBD clinical toolkit, future research must prioritize multi-panel biomarker approaches and longitudinal studies to validate diagnostic accuracy across diverse patient populations.